elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38328539-2633E77B-0A2A-4585-9AA7-D66615D4F07B
Q38328539-2633E77B-0A2A-4585-9AA7-D66615D4F07B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38328539-2633E77B-0A2A-4585-9AA7-D66615D4F07B
IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity.
P2860
Q38328539-2633E77B-0A2A-4585-9AA7-D66615D4F07B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38328539-2633E77B-0A2A-4585-9AA7-D66615D4F07B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da781a39d02c82bed6f289cbff056a4ef64a8242
P2860
Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia.